The inactivation of phosphorylase and activation of glycogen synthase in the adipose tissue.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 6773771)

Published in Eur J Biochem on August 01, 1980

Authors

F Sobrino, H G Hers

Articles by these authors

(truncated to the top 100)

A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem (1982) 6.74

The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42

Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04

Fructose 2,6-bisphosphate 2 years after its discovery. Biochem J (1982) 2.91

Control of the fructose-6-phosphate/fructose 1,6-bisphosphate cycle in isolated hepatocytes by glucose and glucagon. Role of a low-molecular-weight stimulator of phosphofructokinase. Biochem J (1980) 2.88

The control of glycogen metabolism in the liver. Annu Rev Biochem (1976) 2.85

Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem J (1980) 2.79

Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem (1983) 2.63

The abnormalities of lysosomal enzymes in mucopolysacc- haridoses. Eur J Biochem (1968) 2.55

Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-biphosphate. Proc Natl Acad Sci U S A (1981) 2.44

Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol (1994) 2.41

The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after the administration of glucose to mice and rats. The mechanism of the hepatic threshold to glucose. Eur J Biochem (1974) 2.10

Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes. Proc Natl Acad Sci U S A (1976) 2.04

The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase. Biochem J (1977) 1.96

Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci U S A (1981) 1.91

Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J Virol (1991) 1.89

Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology (1985) 1.84

Control of gluconeogenesis and of enzymes of glycogen metabolism in isolated rat hepatocytes. A parallel study of the effect of phenylephrine and of glucagon. Biochem J (1978) 1.81

The stimulation of liver phosphorylase b by AMP, fluoride and sulfate. A technical note on the specific determination of the a and b forms of liver glycogen phosphorylase. Eur J Biochem (1975) 1.80

Fructose-2,6-bisphosphatase from rat liver. Eur J Biochem (1982) 1.75

Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. J Virol (1992) 1.72

Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1989) 1.71

Phosphorylation of glucose in isolated rat hepatocytes. Sigmoidal kinetics explained by the activity of glucokinase alone. Biochem J (1978) 1.70

Study of the fructose 6-phosphate/fructose 1,6-bi-phosphate cycle in the liver in vivo. Biochem J (1980) 1.69

Hormonal control of fructose 2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem J (1983) 1.64

Hormonal and ionic control of the glycogenolytic cascade in rat liver. Biochem J (1977) 1.64

A kinetic study of the soluble 5'-nucleotidase of rat liver. Biochem J (1977) 1.62

Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem (1999) 1.59

Phosphofructokinase 2: the enzyme that forms fructose 2,6-bisphosphate from fructose 6-phosphate and ATP. Biochem Biophys Res Commun (1981) 1.58

Regulation in vitro and in vivo of adenosine 3':5'-monophosphate-dependent inactivation of rat-liver pyruvate kinase type L. Eur J Biochem (1977) 1.57

A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol (1990) 1.57

Mucopolysaccharidosis by absence of alpha-fucosidase. Lancet (1968) 1.56

Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene (1986) 1.53

Purine catabolism in isolated rat hepatocytes. Influence of coformycin. Biochem J (1980) 1.52

Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc Natl Acad Sci U S A (1983) 1.52

Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration. Biochem J (1984) 1.49

Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med (1999) 1.45

The control of liver glycogen synthetase phosphatase by phosphorylase. Eur J Biochem (1971) 1.37

A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36

Formation of fructose 2,6-bisphosphate from fructose 1,6-bisphosphate by intramolecular cyclisation followed by alkaline hydrolysis. Eur J Biochem (1981) 1.31

Rodent and human acid -glucosidase. Purification, properties and inhibition by antibodies. Investigation in type II glycogenosis. Eur J Biochem (1972) 1.30

The role of glucose, glucagon and glucocorticoids in the regulation of liver glycogen synthesis. Eur J Biochem (1968) 1.29

A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol (2001) 1.29

Glycogen metabolism in the liver of the foetal rat. Biochem J (1974) 1.29

The stimulation of yeast phosphofructokinase by fructose 2,6-bisphosphate. FEBS Lett (1982) 1.27

Synthesis of a stimulator of phosphofructokinase, most likely fructose 2,6-bisphosphate, from phosphoric acid and fructose 6-phosphoric acid. Biochem Biophys Res Commun (1980) 1.26

The control of glycogen synthesis in the liver. Adv Enzyme Regul (1970) 1.25

The control of glycogen metabolism in yeast. 1. Interconversion in vivo of glycogen synthase and glycogen phosphorylase induced by glucose, a nitrogen source or uncouplers. Eur J Biochem (1988) 1.23

On the use of (3H, 14C)labelled glucose in the study of the so-called "futile cycles" in liver and muscle. Biochem Biophys Res Commun (1974) 1.22

Design of primers for PCR amplification of highly variable genomes. Comput Appl Biosci (1993) 1.16

The effect of glucose and of a treatment by glucocorticoids on the activation in vitro of liver glycogen synthetase. Eur J Biochem (1970) 1.15

The stimulation of glycogen synthesis and of glycogen synthetase in the liver by the administration of glucose. Eur J Biochem (1967) 1.15

The interaction of liver phosphorylase a with glucose and AMP. Eur J Biochem (1974) 1.15

Induction of pyrophosphate:fructose 6-phosphate 1-phosphotransferase by anoxia in rice seedlings. Plant Physiol (1990) 1.14

Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene (1988) 1.12

Inactivation of phosphofructokinase 2 by cyclic AMP - dependent protein kinase. Biochem Biophys Res Commun (1981) 1.12

A study of the reaction catalysed by the liver branching enzyme. Biochem J (1966) 1.11

The influence of inorganic phosphate, adenosine triphosphate and glucose 6-phosphate on the activity of liver glycogen synthetase. Eur J Biochem (1968) 1.11

On the mechanism of inhibition of neutral liver fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate. Eur J Biochem (1983) 1.11

A molecular order in the synthesis and degradation of glycogen in the liver. Eur J Biochem (1979) 1.10

VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10

The ability of adenosine to decrease the concentration of fructose 2,6-bisphosphate in isolated hepatocytes. A cyclic AMP-mediated effect. Biochem J (1984) 1.09

The pathway of adenine nucleotide catabolism and its control in isolated rat hepatocytes subjected to anoxia. Biochem J (1982) 1.09

Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance. Biochem J (1973) 1.08

The mechanism by which glucose increases fructose 2,6-bisphosphate concentration in Saccharomyces cerevisiae. A cyclic-AMP-dependent activation of phosphofructokinase 2. Eur J Biochem (1984) 1.07

Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol (1991) 1.07

Effects of glucose and glucagon on the fructose 2,6-bisphosphate content of pancreatic islets and purified pancreatic B-cells. A comparison with isolated hepatocytes. Biochem J (1984) 1.07

Utile and futile cycles in the liver. Biochem Biophys Res Commun (1974) 1.06

Characterization of trehalose-6-phosphate synthase and trehalose-6-phosphate phosphatase of Saccharomyces cerevisiae. Eur J Biochem (1989) 1.06

Purification and properties of phosphofructokinase 2/fructose 2,6-bisphosphatase from chicken liver and from pigeon muscle. Eur J Biochem (1986) 1.06

The subgroups of type 3 glycogenosis. Eur J Biochem (1967) 1.05

Fructose 2,6-bisphosphate versus cyclic AMP in the liver and in lower eukaryotic cells. Curr Top Cell Regul (1985) 1.05

Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose 2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei. Eur J Biochem (1987) 1.05

Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution. Proc Natl Acad Sci U S A (1988) 1.05

Interference by pyruvate carboxylase in the measurement of acetyl-CoA carboxylase in crude liver preparations. Biochem J (1982) 1.05

A simplified procedure for the assay of adenosine 3':5'-monophosphate by the activation of liver phosphorylase. Eur J Biochem (1974) 1.04

Purification and properties of spinach leaf phosphofructokinase 2/fructose 2,6-bisphosphatase. Eur J Biochem (1986) 1.04

Pathways of adenine nucleotide catabolism in erythrocytes. J Clin Invest (1986) 1.03

The effect of glucose and of a treatment by glucocorticoids on the inactivation in vitro of liver glycogen phosphorylase. Eur J Biochem (1970) 1.03

Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology (1999) 1.02

The interconversion of liver glycogen synthetase a and b in vitro. Eur J Biochem (1968) 1.02

Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication. J Gen Virol (2001) 1.01

Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J Gen Virol (1998) 1.00

The control of trehalose biosynthesis in Saccharomyces cerevisiae: evidence for a catabolite inactivation and repression of trehalose-6-phosphate synthase and trehalose-6-phosphate phosphatase. Yeast (1992) 0.98

Structure and configuration of fructose 2,6-bisphosphate by 31P and 13C nuclear magnetic resonance. Eur J Biochem (1981) 0.97

Effect of benzoate on the metabolism of fructose 2,6-bisphosphate in yeast. Eur J Biochem (1986) 0.97

Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology (1990) 0.96

Mechanism of activation of glycogen phosphorylase by fructose in the liver. Stimulation of phosphorylase kinase related to the consumption of adenosine triphosphate. Biochem J (1979) 0.96

In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J Gen Virol (1998) 0.96

Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch Virol (1994) 0.95

Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing of foot-and-mouth disease virus. Virology (1992) 0.95

Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Virus Res (1990) 0.95

The effect of insulin on the glycogenolytic cascade and on the activity of glycogen synthase in the liver of anaesthetized rabbits. Biochem J (1977) 0.95

Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol (2001) 0.95

Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J Gen Virol (1992) 0.94

[The ultrastructure of the liver in various thesaurismoses]. Rev Int Hepatol (1967) 0.94

Glycogen storage diseases. Biochimie (1972) 0.94

5'-Nucleotidase activities in human erythrocytes. Identification of a purine 5'-nucleotidase stimulated by ATP and glycerate 2,3-bisphosphate. Biochem J (1988) 0.94

Extracellular metabolites in suspensions of isolated hepatocytes. Biochem J (1987) 0.93

The stimulation of phosphofructokinase from human erythrocytes by fructose 2,6-bisphosphate. FEBS Lett (1982) 0.93